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ABSTRACT
Making claims on the health effects of foods currently presents major challenges to
nutrition science. As a case in point, oat β-glucan has been shown to deliver a number
of health benefits, including an ability to lower cholesterol levels as well as reducing
glucose and insulin responses to a meal. These physiological functions are related to
the viscosity and solubility of the β-glucan, with the viscosity a function of
concentration and molecular weight. Further, despite epidemiological evidence that
high fibre diets are associated with lower levels of overweight and obesity in
populations, and experimental evidence that fibre will “make you feel fuller for
longer”, there is little evidence linking specific fibres with weight control. Changes to
regulations governing health claims in Australia and New Zealand are currently under
review, and while they reflect European and other regional positions in allowing
claims for β-glucan and cholesterol, they do not address other health benefits such as
weight loss. This thesis provides a novel approach to evidence based research in food
by combining studies in food science, acute meal tests and longer term dietary
interventions. The hypothesis examined in this thesis is that overweight individuals
following a nutritionally-balanced, energy-restricted diet including oat β-glucan will
experience increased satiety and lose more weight than if they followed the same diet
without the added β-glucan.
Product development studies examined the effects of extrusion on the important
physical attributes of β-glucan included in a ready-to-eat cereal product. It did not
prove difficult to produce a cereal that maintained β-glucan at high molecular weight
(>1 million) and was viscous at high concentration (up to 5g β-glucan/cereal serve).
Extrusion improved solubility which means the effects of downstream processing in
this manner are likely to improve the physiological effects of β-glucan in cereals.
Results of a meal-test study with fourteen subjects found that increasing doses of βglucan up to 5.5 g, decreased insulin levels (P=0.011) and increased subjective
satiety measured by visual analogue scales (P=0.039). Increasing doses of β-glucan
were correlated with increased plasma concentrations of cholecystokinin (CCK) and
peptide Y-Y (PYY) (R2=0.970 and 0.994 respectively). Food intake at a subsequent
meal was decreased with inclusion of β-glucan in the earlier test meal, although the
differences were not statistically significant.

A 3-month randomised controlled trial of 66 overweight women was then conducted
to investigate the effects of two different doses of β-glucan (5-6g or 8-9g) on weight
loss within an energy-restricted regimen. Outcome measures included weight loss
and markers of appetite regulation (hormones) as well as changes in metabolic
variables related to cardiovascular disease. All groups lost weight (approximately 5%
of body weight) and showed a reduced waist circumference (P<0.001 for both). The
study sample also showed reductions in total cholesterol, LDL, HDL, leptin, PYY,
glucagon-like-peptide-1 (GLP-1) values and an increase in CCK levels. No
significant differences were noted between the groups for all outcome values except
fasting PYY levels (P=0.018) but levels did not correlate with increasing dose.
Thus, the addition of oat β-glucan did not enhance the effect of energy restriction on
weight loss in mildly overweight women, although large standard deviations in
observed results, suggested that individual responsiveness makes elucidation of
significant changes difficult. Adding these results to the body of evidence, it seems
that some evidence exists relating to β-glucan and satiety with the most likely
mechanisms relating to changes in absorption of nutrients and resultant release of
anorexigenic hormones. There appears to be insufficient evidence to suggest the
validity of a claim related to β-glucan and weight control. Further research of this
nature would build on the knowledge of the mechanisms of satiety elucidated here,
and this would further investigate how β-glucan and other soluble fibres may help
weight control over longer time frames.

